Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.45 USD | +7.81% | +18.85% | -36.68% |
Valuation
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|
Capitalization 1 | 43.12 | 21.38 | 24.49 | 34.73 | - | - |
Enterprise Value (EV) 1 | 43.12 | 21.38 | 24.49 | 34.73 | 34.73 | 34.73 |
P/E ratio | -4 x | -2.16 x | -2.31 x | -4.53 x | -3.54 x | -10 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | 2.85 x |
EV / Revenue | - | - | - | - | - | 2.85 x |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | -7,269,507 x | - | - | - | - | - |
FCF Yield | -0% | - | - | - | - | - |
Price to Book | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 8,908 | 9,098 | 10,694 | 23,950 | - | - |
Reference price 2 | 4.840 | 2.350 | 2.290 | 1.450 | 1.450 | 1.450 |
Announcement Date | 3/30/22 | 3/2/23 | 4/1/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | 12.19 |
EBITDA | - | - | - | - | - | - | - |
EBIT 1 | - | -5.671 | -9.95 | -11.4 | -8.55 | -13.01 | -6.732 |
Operating Margin | - | - | - | - | - | - | -55.23% |
Earnings before Tax (EBT) 1 | - | -6.324 | -9.889 | -10.23 | -8.115 | -12.86 | -6.582 |
Net income 1 | -3.798 | -6.324 | -9.889 | -10.23 | -8.115 | -12.86 | -6.582 |
Net margin | - | - | - | - | - | - | -54% |
EPS 2 | -0.3400 | -1.210 | -1.090 | -0.9900 | -0.3200 | -0.4100 | -0.1450 |
Free Cash Flow | - | -5.931 | - | - | - | - | - |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 4/2/21 | 3/30/22 | 3/2/23 | 4/1/24 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBIT 1 | -2.356 | -3.005 | -2.614 | -2.161 | -2.17 | -3.261 | -3.375 | -2.983 | -1.777 | -2.476 | -2.1 | -2.1 | -2.1 | - | - |
Operating Margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | -2.355 | -3.003 | -2.594 | -2.136 | -2.156 | -3.257 | -2.327 | -1.421 | -3.227 | -1.076 | -1.96 | -1.98 | -1.99 | - | - |
Net income 1 | -2.355 | -3.003 | -2.594 | -2.136 | -2.156 | -3.257 | -2.327 | -1.421 | -3.227 | -1.076 | -1.96 | -1.98 | -1.99 | - | - |
Net margin | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EPS 2 | -0.1200 | -0.3300 | -0.2900 | -0.2400 | -0.2300 | -0.3600 | -0.2200 | -0.1300 | -0.3000 | -0.0700 | -0.0800 | -0.0700 | -0.0700 | - | - |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/30/22 | 5/13/22 | 8/12/22 | 11/14/22 | 3/2/23 | 5/12/23 | 8/16/23 | 11/13/23 | 4/1/24 | 5/10/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
Free Cash Flow | - | -5.93 | - | - | - | - | - |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - |
Announcement Date | 4/2/21 | 3/30/22 | 3/2/23 | 4/1/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.68% | 34.73M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- RNXT Stock
- Financials RenovoRx, Inc.